Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease-Reference-Cited by-同舟云学术

Biomarkers in Amyloid-β Immunotherapy Trials in Alzheimer’s Disease

Published:2013-06-25 Issue:1 Volume:39 Page:189-201
ISSN:0893-133X
Container-title:Neuropsychopharmacology
language:en
Short-container-title:Neuropsychopharmacol

Author:

Blennow Kaj,Hampel Harald,Zetterberg Henrik

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Pharmacology

Link

http://www.nature.com/articles/npp2013154.pdf

Reference115 articles.

1. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011). The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging–Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7: 270–279.

2. Andersson M, Alvarez-Cermeño J, Bernardi G, Cogato I, Fredman P, Frederiksen J et al (1994). Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report. J Neurol Neurosurg Psychiatry 57: 897–902.

3. Andreasen N, Minthon L, Vanmechelen E, Vanderstichele H, Davidsson P, Winblad B et al (1999). CSF-tau and CSF-Aβ42 as predictors of development of Alzheimer’s disease in patients with mild cognitive impairment. Neurosci Lett 273: 5–8.

4. Andreasen N, Minthon L, Davidsson P, Vanmechelen E, Vanderstichele H, Winblad B et al (2001). Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer’s disease in clinical practice. Arch Neurol 58: 373–379.

5. Andreasen N, Blennow K, Zetterberg H (2010). Neuroinflammation screening in immunotherapy trials against Alzheimer’s disease. Int J Alzheimers Dis 2010: 638379.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy in Alzheimer’s disease: focusing on the efficacy of gantenerumab on amyloid-β clearance and cognitive decline;Journal of Pharmacy and Pharmacology;2024-05-20

2. Agents at the Peak of US FDA Approval for the Treatment of Alzheimer’s Disease;Neurological Research;2024-01-10

3. An examination of Alzheimer’s disease and white matter from 1981 to 2023: a Bibliometric and visual analysis;Frontiers in Neurology;2023-11-14

4. Recent Trends in Active and Passive Immunotherapies of Alzheimer’s Disease;Antibodies;2023-06-19

5. Plasma Biomarkers of Alzheimer’s Disease: A Review of Available Assays, Recent Developments, and Implications for Clinical Practice;Journal of Alzheimer's Disease Reports;2023-05-03